Literature DB >> 23738297

Bioactive factors for tissue regeneration: state of the art.

Shinsuke Ohba1, Hironori Hojo, Ung-Il Chung.   

Abstract

THERE ARE THREE COMPONENTS FOR THE CREATION OF NEW TISSUES: cell sources, scaffolds, and bioactive factors. Unlike conventional medical strategies, regenerative medicine requires not only analytical approaches but also integrative ones. Basic research has identified a number of bioactive factors that are necessary, but not sufficient, for organogenesis. In skeletal development, these factors include bone morphogenetic proteins (BMPs), transforming growth factor β TGF-β, Wnts, hedgehogs (Hh), fibroblast growth factors (FGFs), insulin-like growth factors (IGFs), SRY box-containing gene (Sox) 9, Sp7, and runt-related transcription factors (Runx). Clinical and preclinical studies have been extensively performed to apply the knowledge to bone and cartilage regeneration. Given the large number of findings obtained so far, it would be a good time for a multi-disciplinary, collaborative effort to optimize these known factors and develop appropriate drug delivery systems for delivering them.

Entities:  

Keywords:  bone regeneration; cartilage regeneration; chondrocyte; mesenchymal cell; osteoblast

Year:  2012        PMID: 23738297      PMCID: PMC3666524     

Source DB:  PubMed          Journal:  Muscles Ligaments Tendons J        ISSN: 2240-4554


  157 in total

1.  A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo-controlled trial.

Authors:  Hiroshi Kawaguchi; Hiroyuki Oka; Seiya Jingushi; Toshihiro Izumi; Masao Fukunaga; Katsumi Sato; Takashi Matsushita; Kozo Nakamura
Journal:  J Bone Miner Res       Date:  2010-06-07       Impact factor: 6.741

2.  Ihh controls cartilage development by antagonizing Gli3, but requires additional effectors to regulate osteoblast and vascular development.

Authors:  Matthew J Hilton; Xiaolin Tu; Julie Cook; Hongliang Hu; Fanxin Long
Journal:  Development       Date:  2005-09-01       Impact factor: 6.868

3.  Critical-size calvarial bone defects healing in a mouse model with silk scaffolds and SATB2-modified iPSCs.

Authors:  Jin-Hai Ye; Yuan-Jin Xu; Jun Gao; Shi-Guo Yan; Jun Zhao; Qisheng Tu; Jin Zhang; Xue-Jing Duan; Cesar A Sommer; Gustavo Mostoslavsky; David L Kaplan; Yu-Nong Wu; Chen-Ping Zhang; Lin Wang; Jake Chen
Journal:  Biomaterials       Date:  2011-04-13       Impact factor: 12.479

4.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

5.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation.

Authors:  A Montero; Y Okada; M Tomita; M Ito; H Tsurukami; T Nakamura; T Doetschman; J D Coffin; M M Hurley
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

6.  Porous gelatin-chondroitin-hyaluronate tri-copolymer scaffold containing microspheres loaded with TGF-beta1 induces differentiation of mesenchymal stem cells in vivo for enhancing cartilage repair.

Authors:  Hongbin Fan; Yunyu Hu; Ling Qin; Xusheng Li; Hong Wu; Rong Lv
Journal:  J Biomed Mater Res A       Date:  2006-06-15       Impact factor: 4.396

7.  Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth.

Authors:  F Lupu; J D Terwilliger; K Lee; G V Segre; A Efstratiadis
Journal:  Dev Biol       Date:  2001-01-01       Impact factor: 3.582

Review 8.  In vitro and in vivo effects of ipriflavone on bone formation and bone biomechanics.

Authors:  R Civitelli
Journal:  Calcif Tissue Int       Date:  1997       Impact factor: 4.333

9.  Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7.

Authors:  R T Franceschi; D Wang; P H Krebsbach; R B Rutherford
Journal:  J Cell Biochem       Date:  2000-06-06       Impact factor: 4.429

Review 10.  TGF-β and BMP signaling in osteoblast differentiation and bone formation.

Authors:  Guiqian Chen; Chuxia Deng; Yi-Ping Li
Journal:  Int J Biol Sci       Date:  2012-01-21       Impact factor: 6.580

View more
  4 in total

1.  Mesenchymal stem cell response to growth factor treatment and low oxygen tension in 3-dimensional construct environment.

Authors:  Thomas John Sakrison Durant; Nathaniel Dyment; Mary Beth R McCarthy; Mark P Cote; Robert A Arciero; Augustus D Mazzocca; David Rowe
Journal:  Muscles Ligaments Tendons J       Date:  2014-05-08

Review 2.  "Ins" and "Outs" of mesenchymal stem cell osteogenesis in regenerative medicine.

Authors:  Dean T Yamaguchi
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

3.  Mesenchymal stem cells overexpressing Ihh promote bone repair.

Authors:  Shasha Zou; Tingting Chen; Yanan Wang; Ruhui Tian; Lingling Zhang; Pingping Song; Shi Yang; Yong Zhu; Xizhi Guo; Yiran Huang; Zheng Li; Lixin Kan; Hongliang Hu
Journal:  J Orthop Surg Res       Date:  2014-10-28       Impact factor: 2.359

Review 4.  Implementation of Endogenous and Exogenous Mesenchymal Progenitor Cells for Skeletal Tissue Regeneration and Repair.

Authors:  Salomi Desai; Chathuraka T Jayasuriya
Journal:  Bioengineering (Basel)       Date:  2020-08-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.